Search

everythinglearnresearchcommunity

for

Search:↓

These medications for BPH have known risks and may have new side effects.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Alpha-blocker therapy may not be needed long-term when combined with finasteride for BPH.

Finasteride weakens the bone-protective effects of certain blockers in low androgen conditions.

Amlodipine impairs fertility in male rats by affecting sperm and testicular structure.

A(1-7) treatment reduces symptoms of lupus in mice.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

AH-001 could be a safer and more effective treatment for hair loss.

Age and other health issues affect erectile dysfunction more than finasteride or alpha-blockers.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Tedisamil and glibenclamide affect cromakalim and minoxidil sulphate differently in rat aorta.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Alfuzosin reduces short-term surgery need after catheter removal, but long-term benefits are unclear; combination therapy may help prevent urinary issues.

The inhibitor affects androgen metabolism but not ovarian function.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Blocking adenosine A2B receptor may prevent or treat hearing loss.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Propranolol affects heart rate and renin levels in minoxidil-treated patients.